authors
- Trudel, Suzanne
- McCurdy, Arleigh
- Sutherland, Heather
- Louzada, Martha
- Venner, Christopher
- White, Darrell
- Mian, Hira
- Kotb, Rami
- Othman, Ibraheem
- Camacho, Fernando
- Fu, Molei
- Gul, Engin
- Reece, Donna
P-222: Extended follow-up safety and efficacy results of Belantamab mafodotin (Belamaf) 1.92 mg/kg or 2.5 mg/kg combined with POM and DEX for the treatment of relapsed/refractory Multiple Myeloma
Conferences
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- October 2021